Also listed on Capella Bioscience Ltd., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Oct 27, 2039 · High confidence
20-year base term ends Jan 24, 2039
Jan 24, 2019
Oct 27, 2039
Feb 18, 2025
This patent's term runs 276 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 24, 2019, when application 16/256,688, the earliest non-provisional in its chain, was filed (this one was filed Apr 22, 2022) | Jan 24, 2039 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +276 days, USPTO patent term adjustment record | Oct 27, 2039 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,312,781) | resolves to Oct 27, 2039, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 27, 2039 | High confidence |
This family
| US 11,312,781 | Lapsed on the fee record Apr 2026 | Apr 2026 |
| US 12,227,580 | this patent Oct 2039 | Oct 2039 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 28, 2023 Reel 65056, frame 399 | Capella Bioscience Ltd. | Centessa Pharmaceuticals (UK) Limited | Assignment of Assignor's Interest |
| Oct 31, 2023 Reel 65403, frame 606 | Holmes, Steve | Capella Bioscience Ltd. | Assignment of Assignor's Interest |
| Dec 31, 2024 Reel 69708, frame 39 | Centessa Pharmaceuticals (UK) Limited | Oxford Finance LLC | Security Interest |
| Jun 24, 2026 Reel 75069, frame 879 | Oxford Finance LLC | Centessa Pharmaceuticals (UK) Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 11,312,781, ends no earlier than this term, so it caps nothing.